The guidance withdrawal is the most consequential signal — it removes the $51-55M FY2026 revenue target and introduces binary CMS reimbursement risk. Monitor the comment period on the proposed 2027 rule and any interim updates. The stock is likely to reprice lower on uncertainty; a recovery catalyst requires a favorable final rule in Q4 2026 or a material beat on the withdrawn guidance range.
Price Chart
Executive Summary
SANUWAVE reported Q2 2026 revenue of $9.7M, down 3% YoY from $10.1M, swinging to a net loss of $0.7M vs net income of $0.6M a year ago. The company withdrew its full-year 2026 guidance due to an adverse CMS proposed rule for 2027 reimbursement, creating significant revenue visibility risk. Ultramist applicator volumes hit a record, but system sales fell sharply and gross margins compressed, reinforcing a deteriorating fundamental picture.
Key Financial Metrics
Key Facts
- Q2 2026 revenue $9.7M, down 3% YoY from $10.1M
- GAAP operating loss of $(0.3)M vs operating income of $1.4M in Q2 2025
- Net loss of $0.7M vs net income of $0.6M in Q2 2025
- Adjusted EBITDA fell to $1.2M from $3.2M YoY
- Gross margin contracted to 76.2% from 78.1%
- Ultramist system sales dropped to 82 units from 116 YoY
- Full-year 2026 guidance withdrawn due to CMS proposed rule for 2027 reimbursement
- Company will not provide guidance until after CMS final rule expected in Q4 2026
Financial Impact
Revenue decline of ~$0.4M YoY; operating income swing of -$1.7M; net income swing of -$1.3M; guidance withdrawal removes forward visibility for $51-55M FY2026 revenue target
Risk Factors
- CMS proposed rule for 2027 97610 reimbursement could significantly reduce practitioner reimbursement, crushing demand
- Emerging secondary market for used Ultramist systems cannibalizing new system sales
- Customer financial distress from allograft reimbursement recoupments
- Cash burn: cash declined to $9.4M from $12.0M at year-end 2025, with $5.6M current portion of term loan due
- No near-term revenue or earnings visibility without guidance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-054459 |
| Document: snwv-20260806.htm | 0001628280-26-054459 |
| Document: 0001628280-26-054459-index-headers.html | 0001628280-26-054459 |
| Document: 0001628280-26-054459-index.html | 0001628280-26-054459 |
| Document: 0001628280-26-054459.txt | 0001628280-26-054459 |
| 8-K Data (Synthetic) | 0001628280-26-054459 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 8-K | $4.65 $4.70 | ▼ −1.08% | ▲ +0.13% | $5.09 (−9.35%) |
Aug 6, 2026 11w ago | 8-K | $5.88 $4.74 | ▲ +19.39% | ▲ +19.79% | $5.09 (+13.52%) |
Aug 6, 2026 11w ago | Press Release | $5.88 $4.74 | ▲ +19.39% | ▲ +19.79% | $5.09 (+13.52%) |
Jul 30, 2026 12w ago | Press Release | $6.17 $5.88 | ▼ −4.70% | ▼ −8.21% | $5.09 (−17.59%) |
Jun 16, 2026 19w ago | 8-K | $8.51 $8.20 | ▲ +3.64% | ▲ +1.41% | $5.09 (+40.25%) |
Jun 16, 2026 19w ago | Press Release | $8.51 $8.20 | ▲ +3.64% | ▲ +1.41% | $5.09 (+40.25%) |
Jun 11, 2026 19w ago | Institutional Cluster | $14.69 $9.09 | ▼ −38.12% | ▼ −38.55% | $5.09 (−65.38%) |
May 12, 2026 23w ago | Press Release | $18.94 $16.69 | ▼ −11.88% | ▼ −10.72% | $5.09 (−73.15%) |
May 6, 2026 24w ago | Press Release | $16.65 $18.94 | ▲ +13.75% | ▲ +12.25% | $5.09 (−69.46%) |
Apr 16, 2026 27w ago | 8-K | $20.61 $18.70 | ▼ −9.27% | ▼ −9.82% | $5.09 (−75.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers